Educational
Programs

Millennium Health is dedicated to supporting patient care by providing resources and education. We have a variety of educational pieces and technical bulletins designed to help you interpret test results and support clinical decision-making.

Our education programs cover a myriad of topics relevant to your practice and patient population, including the clinical value of drug testing and in the management of pain, mental health, and substance use disorders, risk management when prescribing controlled substances, and current trends in the use of natural and synthetic drugs. Programs can be scheduled with your local Sales Representative to be delivered virtually or live by a member of our field Clinical Affairs team.

Clinical Video Newsletters

Our Clinical Affairs team provides timely updates with our Clinical Video Newsletters.

Signals Vol. 4 Sec. 3

Characterizing the Cannabis Landscape

Signals Vol. 4 Sec. 2

Finding Fentanyl: A Crisis of Co-Positivity

Signals Vol. 4 Sec. 1

Depicting Illicit Drug Use Through 2021

Drug and Alcohol Dependence

Publication in Drug and Alcohol Dependence:

Seasonal and Regional Influences in Alcohol Consumption: An Analysis of Near-Real-Time Urine Drug Testing Results in Those Seeking Health Care

JAMA Buprenorphine Study

Publication in JAMA Network Open: Polysubstance Use Among Patients Treated with Buprenorphine

Publication in Journal of Addiction Medicine

Publication in Journal of Addiction Medicine reveals increase in UDT positivity for methamphetamine alone and in combination with other substances

Publication in Drug and Alcohol Dependence

Publication in Drug and Alcohol Dependence
Fentanyl analog positivity among near-real-time urine drug test results in patients seeking health care

Co-Authored Study with HHS in JAMA

Co-Authored Study with U.S. Department of Health & Human Services in JAMA

Educational Webinars

The following educational webinars are available on-demand for your convenience.

Urine Drug Testing Interpretation: A Toxicologist’s Perspective on Common Clinical Challenges

Interpreting urine drug testing (UDT) results can present clinicians a host of challenges. Assessing specimen tampering, marijuana abstinence, and alcohol consumption are particularly challenging, common scenarios. This case-based program, led by toxicologists, will highlight these difficult scenarios, giving clinicians a greater understanding of each to support improved clinical decision making.

Objectives: Upon completion of this session participants will be able to:

Briefly overview the clinical use of urine drug testing
Identify the major markers that constitute specimen validity testing and what each means to UDT interpretation
Recognize ways patients may attempt to circumvent UDT through dilution, adulteration and substitution methods
Utilize tools and resources to create risk management plans for patients in practice
Discuss UDT interpretation of alcohol use

Appropriate Urine Drug Testing in Substance Use Disorders: Clinical Consensus Recommendations

When used appropriately, urine drug testing and medication monitoring in substance use disorders can provide objective data that healthcare practitioners may employ in the diagnosis, active treatment, and recovery phases of care. A project to develop professional consensus on the appropriate use of UDT in identifying and treating substance use disorders was necessitated by a general lack of clinical knowledge and standards. This presentation will focus on a review of clinical indicators, scientific methods, patient-centered substance use testing, and the recommendations on testing from this clinical consensus project.

Objectives: Upon completion of this session participants will be able to:

Discuss the clinical need and value of UDT in the diagnosis and treatment of SUD.
Outline the clinical consensus recommendations for UDT in diagnosis and treatment of SUD related to:
- Test methods & selection
- Practice recommendations
- Test frequency based on stages of treatment and recovery
List reasons for medically necessary and appropriate UDT.
Document reasons for drug testing, review of test results and use of results in the treatment plan to support medical necessity.

Urine Drug Testing (UDT) in Substance Use Disorder (SUD) Treatment: A Consensus-Based Ethical Approach

What are the concerns related to appropriate utilization of UDT in the diagnosis and treatment of SUDs? Featuring Michael C. Barnes, Esq., executive director of the Center for Lawful Access and Abuse Deterrence (CLAAD), and Kenneth L. Kirsh, PhD, clinical psychologist, author and lecturer on pain and addiction, this webcast will describe a clinical approach for utilizing UDT in the treatment of SUDs. Scenarios which may give rise to civil and criminal liability, with examples of government and payer policy responses, will be presented during this educational program.

Objectives: Upon completion of this session participants will be able to:

Identify concerns related to the appropriate use of UDT in the diagnosis and treatment of SUDs.
Describe a clinical approach for utilizing UDT in the identification and management of SUDs.
Recognize scenarios that may give rise to civil and criminal liability for practitioners related to waste, fraud and abuse in UDT.
Be aware of government and payer policy responses to UDT utilization concerns.

The Appropriate Utilization of Urine Drug Testing in Pain Management

Join nationally recognized thought leaders in pain management, Drs. Howard Heit and Douglas Gourlay, in a lively discussion about the appropriate use of urine drug testing in pain management. This session will focus on patient-centered, guideline supported testing. They will share case examples that demonstrate medically appropriate testing, discuss presumptive and definitive testing methods, and documentation of test results to support your testing decisions. Several updated clinical resources on UDT will be provided.

Objectives: Upon completion of this session participants will be able to:

Define the value of patient-centered UDT in pain management.
Explain how UDT is used for patient advocacy, safe prescribing and identifying possible misuse or diversion.
Describe the role of risk stratification in pain management and urine drug testing guidelines.
Review components of documentation to support patient-centered, risk stratified, guideline-supported testing.

Managing Risk in the Treatment of Chronic Pain

Utilizing opioid therapy for the management of chronic pain must involve careful patient selection and evaluation of risk versus benefit, including the risks of misuse, diversion, overdose, and substance use disorders. Chronic opioid therapy should also be accompanied by an ongoing, multifaceted monitoring plan. Through discussion of current literature and case study application, this program outlines the necessary steps to evaluate risk, stratify patients, and create a monitoring plan based on individual risk level. Relevant tools and resources are provided for practical application and creation of risk management plans in clinical practice.

Objectives: Upon completion of this session participants will be able to:

Discuss the current landscape in use of opioids for chronic pain management
Identify the steps to a chronic opioid therapy risk management plan
Create a risk management plan based on patient case
Utilize tools and resources to create risk management plans for patients in practice